Sign In

Login

Password

Forgot Password ? Sign Up

MAD2L2 (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "MAD2L2" in Hungarian language version.

refsWebsite
Global rank Hungarian rank
16nih.gov
4th place
11th place
9doi.org
2nd place
8th place

doi.org

dx.doi.org

  • Cahill DP, da Costa LT, Carson-Walter EB, Kinzler KW, Vogelstein B, Lengauer C (1999. augusztus 1.). „Characterization of MAD2B and other mitotic spindle checkpoint genes”. Genomics 58 (2), 181–187. o. DOI:10.1006/geno.1999.5831. PMID 10366450. 
  • Pirouz M, Rahjouei A, Shamsi F, Eckermann KN, Salinas-Riester G, Pommerenke C, Kessel M (2015. április 30.). „Destabilization of pluripotency in the absence of Mad2l2”. Cell Cycle 14 (10), 1596–1610. o. DOI:10.1080/15384101.2015.1026485. PMID 25928475. PMC 4614513. 
  • Paniagua I, Tayeh Z, Falcone M, Hernández Pérez S, Cerutti A, Jacobs JJL (2022. szeptember 8.). „MAD2L2 promotes replication fork protection and recovery in a shieldin-independent and REV3L-dependent manner”. Nat Commun 13 (1), 5167. o. DOI:10.1038/s41467-022-32861-5. PMID 36075897. PMC 9458726. 
  • Li Y, Li L, Chen M, Yu X, Gu Z, Qiu H, Qin G, Long Q, Fu X, Liu T, Li W, Huang W, Shi D, Kang T, Luo M, Wu X, Deng W (2018. február 13.). „MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation”. Mol Oncol 12 (3), 391–405. o. DOI:10.1002/1878-0261.12173. PMID 29360267. PMC 5830628. 
  • Li L, Jiang P, Hu W, Zou F, Li M, Rao T, Ruan Y, Yu W, Ning J, Cheng F (2024. március 21.). „AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2”. J Transl Med 22 (1), 295. o. DOI:10.1186/s12967-024-05099-6.. PMID 38515112. PMC 10956193. 
  • Nelson KK, Schlöndorff J, Blobel CP (1999. november 1.). „Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta”. Biochem. J. 343 (3), 673–680. o. DOI:10.1042/0264-6021:3430673. PMID 10527948. PMC 1220601. 
  • Murakumo Y, Roth T, Ishii H, Rasio D, Numata S, Croce CM, Fishel R (2000. február 1.). „A human REV7 homolog that interacts with the polymerase zeta catalytic subunit hREV3 and the spindle assembly checkpoint protein hMAD2”. J. Biol. Chem. 275 (6), 4391–4397. o. DOI:10.1074/jbc.275.6.4391. PMID 10660610. 
  • Murakumo Y, Ogura Y, Ishii H, Numata S, Ichihara M, Croce CM, Fishel R, Takahashi M (2001. szeptember 1.). „Interactions in the error-prone postreplication repair proteins hREV1, hREV3, and hREV7”. J. Biol. Chem. 276 (38), 35644–35651. o. DOI:10.1074/jbc.M102051200. PMID 11485998. 
  • Nelson KK, Schlöndorff J, Blobel CP (1999). „Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta”. Biochem. J. 343 (3), 673–680. o. DOI:10.1042/0264-6021:3430673. PMID 10527948. PMC 1220601. 

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Cahill DP, da Costa LT, Carson-Walter EB, Kinzler KW, Vogelstein B, Lengauer C (1999. augusztus 1.). „Characterization of MAD2B and other mitotic spindle checkpoint genes”. Genomics 58 (2), 181–187. o. DOI:10.1006/geno.1999.5831. PMID 10366450. 
  • Pirouz M, Rahjouei A, Shamsi F, Eckermann KN, Salinas-Riester G, Pommerenke C, Kessel M (2015. április 30.). „Destabilization of pluripotency in the absence of Mad2l2”. Cell Cycle 14 (10), 1596–1610. o. DOI:10.1080/15384101.2015.1026485. PMID 25928475. PMC 4614513. 
  • Paniagua I, Tayeh Z, Falcone M, Hernández Pérez S, Cerutti A, Jacobs JJL (2022. szeptember 8.). „MAD2L2 promotes replication fork protection and recovery in a shieldin-independent and REV3L-dependent manner”. Nat Commun 13 (1), 5167. o. DOI:10.1038/s41467-022-32861-5. PMID 36075897. PMC 9458726. 
  • Li Y, Li L, Chen M, Yu X, Gu Z, Qiu H, Qin G, Long Q, Fu X, Liu T, Li W, Huang W, Shi D, Kang T, Luo M, Wu X, Deng W (2018. február 13.). „MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation”. Mol Oncol 12 (3), 391–405. o. DOI:10.1002/1878-0261.12173. PMID 29360267. PMC 5830628. 
  • Li L, Jiang P, Hu W, Zou F, Li M, Rao T, Ruan Y, Yu W, Ning J, Cheng F (2024. március 21.). „AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2”. J Transl Med 22 (1), 295. o. DOI:10.1186/s12967-024-05099-6.. PMID 38515112. PMC 10956193. 
  • Nelson KK, Schlöndorff J, Blobel CP (1999. november 1.). „Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta”. Biochem. J. 343 (3), 673–680. o. DOI:10.1042/0264-6021:3430673. PMID 10527948. PMC 1220601. 
  • Murakumo Y, Roth T, Ishii H, Rasio D, Numata S, Croce CM, Fishel R (2000. február 1.). „A human REV7 homolog that interacts with the polymerase zeta catalytic subunit hREV3 and the spindle assembly checkpoint protein hMAD2”. J. Biol. Chem. 275 (6), 4391–4397. o. DOI:10.1074/jbc.275.6.4391. PMID 10660610. 
  • Murakumo Y, Ogura Y, Ishii H, Numata S, Ichihara M, Croce CM, Fishel R, Takahashi M (2001. szeptember 1.). „Interactions in the error-prone postreplication repair proteins hREV1, hREV3, and hREV7”. J. Biol. Chem. 276 (38), 35644–35651. o. DOI:10.1074/jbc.M102051200. PMID 11485998. 
  • Nelson KK, Schlöndorff J, Blobel CP (1999). „Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta”. Biochem. J. 343 (3), 673–680. o. DOI:10.1042/0264-6021:3430673. PMID 10527948. PMC 1220601. 

ncbi.nlm.nih.gov

  • Entrez Gene: MAD2L2 MAD2 mitotic arrest deficient-like 2 (yeast)
  • Pirouz M, Rahjouei A, Shamsi F, Eckermann KN, Salinas-Riester G, Pommerenke C, Kessel M (2015. április 30.). „Destabilization of pluripotency in the absence of Mad2l2”. Cell Cycle 14 (10), 1596–1610. o. DOI:10.1080/15384101.2015.1026485. PMID 25928475. PMC 4614513. 
  • Paniagua I, Tayeh Z, Falcone M, Hernández Pérez S, Cerutti A, Jacobs JJL (2022. szeptember 8.). „MAD2L2 promotes replication fork protection and recovery in a shieldin-independent and REV3L-dependent manner”. Nat Commun 13 (1), 5167. o. DOI:10.1038/s41467-022-32861-5. PMID 36075897. PMC 9458726. 
  • Li Y, Li L, Chen M, Yu X, Gu Z, Qiu H, Qin G, Long Q, Fu X, Liu T, Li W, Huang W, Shi D, Kang T, Luo M, Wu X, Deng W (2018. február 13.). „MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation”. Mol Oncol 12 (3), 391–405. o. DOI:10.1002/1878-0261.12173. PMID 29360267. PMC 5830628. 
  • Li L, Jiang P, Hu W, Zou F, Li M, Rao T, Ruan Y, Yu W, Ning J, Cheng F (2024. március 21.). „AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2”. J Transl Med 22 (1), 295. o. DOI:10.1186/s12967-024-05099-6.. PMID 38515112. PMC 10956193. 
  • Nelson KK, Schlöndorff J, Blobel CP (1999. november 1.). „Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta”. Biochem. J. 343 (3), 673–680. o. DOI:10.1042/0264-6021:3430673. PMID 10527948. PMC 1220601. 
  • Nelson KK, Schlöndorff J, Blobel CP (1999). „Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta”. Biochem. J. 343 (3), 673–680. o. DOI:10.1042/0264-6021:3430673. PMID 10527948. PMC 1220601.